Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.

In vitro studies have well established the neuroprotective action of the noble gas argon. However, only limited data from in vivo models are available, and particularly whether postexcitotoxic or postischemic argon can provide neuroprotection in vivo still remains to be demonstrated. Here, we invest...

Full description

Bibliographic Details
Main Authors: Hélène N David, Benoît Haelewyn, Mickael Degoulet, Denis G Colomb, Jean-Jacques Risso, Jacques H Abraini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3285153?pdf=render
_version_ 1811207825604476928
author Hélène N David
Benoît Haelewyn
Mickael Degoulet
Denis G Colomb
Jean-Jacques Risso
Jacques H Abraini
author_facet Hélène N David
Benoît Haelewyn
Mickael Degoulet
Denis G Colomb
Jean-Jacques Risso
Jacques H Abraini
author_sort Hélène N David
collection DOAJ
description In vitro studies have well established the neuroprotective action of the noble gas argon. However, only limited data from in vivo models are available, and particularly whether postexcitotoxic or postischemic argon can provide neuroprotection in vivo still remains to be demonstrated. Here, we investigated the possible neuroprotective effect of postexcitotoxic-postischemic argon both ex vivo in acute brain slices subjected to ischemia in the form of oxygen and glucose deprivation (OGD), and in vivo in rats subjected to an intrastriatal injection of N-methyl-D-aspartate (NMDA) or to the occlusion of middle-cerebral artery (MCAO). We show that postexcitotoxic-postischemic argon reduces OGD-induced cell injury in brain slices, and further reduces NMDA-induced brain damage and MCAO-induced cortical brain damage in rats. Contrasting with its beneficial effect at the cortical level, we show that postischemic argon increases MCAO-induced subcortical brain damage and provides no improvement of neurologic outcome as compared to control animals. These results extend previous data on the neuroprotective action of argon. Particularly, taken together with previous in vivo data that have shown that intraischemic argon has neuroprotective action at both the cortical and subcortical level, our findings on postischemic argon suggest that this noble gas could be administered during but not after ischemia, i.e. before but not after reperfusion has occurred, in order to provide cortical neuroprotection and to avoid increasing subcortical brain damage. Also, the effects of argon are discussed as regards to the oxygen-like chemical, pharmacological, and physical properties of argon.
first_indexed 2024-04-12T04:10:05Z
format Article
id doaj.art-cca6dbcb6cdf41ec9ed7e136aa5ed4a5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T04:10:05Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-cca6dbcb6cdf41ec9ed7e136aa5ed4a52022-12-22T03:48:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0172e3093410.1371/journal.pone.0030934Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.Hélène N DavidBenoît HaelewynMickael DegouletDenis G ColombJean-Jacques RissoJacques H AbrainiIn vitro studies have well established the neuroprotective action of the noble gas argon. However, only limited data from in vivo models are available, and particularly whether postexcitotoxic or postischemic argon can provide neuroprotection in vivo still remains to be demonstrated. Here, we investigated the possible neuroprotective effect of postexcitotoxic-postischemic argon both ex vivo in acute brain slices subjected to ischemia in the form of oxygen and glucose deprivation (OGD), and in vivo in rats subjected to an intrastriatal injection of N-methyl-D-aspartate (NMDA) or to the occlusion of middle-cerebral artery (MCAO). We show that postexcitotoxic-postischemic argon reduces OGD-induced cell injury in brain slices, and further reduces NMDA-induced brain damage and MCAO-induced cortical brain damage in rats. Contrasting with its beneficial effect at the cortical level, we show that postischemic argon increases MCAO-induced subcortical brain damage and provides no improvement of neurologic outcome as compared to control animals. These results extend previous data on the neuroprotective action of argon. Particularly, taken together with previous in vivo data that have shown that intraischemic argon has neuroprotective action at both the cortical and subcortical level, our findings on postischemic argon suggest that this noble gas could be administered during but not after ischemia, i.e. before but not after reperfusion has occurred, in order to provide cortical neuroprotection and to avoid increasing subcortical brain damage. Also, the effects of argon are discussed as regards to the oxygen-like chemical, pharmacological, and physical properties of argon.http://europepmc.org/articles/PMC3285153?pdf=render
spellingShingle Hélène N David
Benoît Haelewyn
Mickael Degoulet
Denis G Colomb
Jean-Jacques Risso
Jacques H Abraini
Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.
PLoS ONE
title Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.
title_full Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.
title_fullStr Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.
title_full_unstemmed Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.
title_short Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.
title_sort ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult
url http://europepmc.org/articles/PMC3285153?pdf=render
work_keys_str_mv AT helenendavid exvivoandinvivoneuroprotectioninducedbyargonwhengivenafteranexcitotoxicorischemicinsult
AT benoithaelewyn exvivoandinvivoneuroprotectioninducedbyargonwhengivenafteranexcitotoxicorischemicinsult
AT mickaeldegoulet exvivoandinvivoneuroprotectioninducedbyargonwhengivenafteranexcitotoxicorischemicinsult
AT denisgcolomb exvivoandinvivoneuroprotectioninducedbyargonwhengivenafteranexcitotoxicorischemicinsult
AT jeanjacquesrisso exvivoandinvivoneuroprotectioninducedbyargonwhengivenafteranexcitotoxicorischemicinsult
AT jacqueshabraini exvivoandinvivoneuroprotectioninducedbyargonwhengivenafteranexcitotoxicorischemicinsult